Labesto, Nadia .

HRN: 27-37-03  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/23/2025
CEFTRIAXONE 1G (VIAL)
06/23/2025
06/29/2025
IV
1gm
Q12
ABI
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Bloodstream    Compliance to guidelines: Compliant To Guidelines